Abstract
After a period of euphoria following the report on the first ex vivo production of monoclonal antibodies (Köhler, 1975), the new “magic bullets” as they were qualified by the press, however did not keep theirs promise. Indeed, apart OKT3 a mouse mAb directed against the T lymphocyte CD3 molecule, the first to get US and European approvals in the prevention of organ rejection in 1986, several trials conducted with other mAbs did not show significant results. These poor effects were mainly due to generation of anti-murine Abs by the patients, hindering the efficacy of the treatment. Moreover, rodent IgG Abs injected to patients have half-life of less than 20 hrs compared to several days for human Igs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Angevin, E., L. Glukhova, C. Pavon, A. Chassevent, M. J. Terrier-Lacombe, A. F. Goguel, J. Bougaran, P. Ardouin, B. H. Court, J. L. Perrin, G. Vallancien, F. Triebel, and B. Escudier. 1999. Human renal cell carcinoma xenografts in SCID mice: tumorigenicity correlates with a poor clinical prognosis. Lab Invest 79:879.
Arafat, W. O., et al. 2000. An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer. Mol Ther 1:545.
Bartlett, J. S., J. Kleinschmidt, R. C. Boucher, and R. J. Samulski. 1999. Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab’gamma)2 antibody. Nat Biotechnol 17:181.
Chapel, A., P. Poncet, T. M. A. Neildez-Nguyen, J. Vétillard, N. Brouard, C. Goupy, G. Chavanel, F. Hirsch, and D. Thierry. 1999. Targeted transfection of IL-3 gene into primary human hematopoietic progenitor cells through the c-kit receptor. Exp Hematol 27:250.
Déas, O., E. Angevin, C. Cherbonnier, A. Senik, B. Charpentier, J. P. Levillain, E. Oosterwijk, F. Hirsch, and A. Durrbach. 2002. In vivo-targeted gene delivery using antibody-based nonviral vector. Hum Gene Ther 13:1101.
Dürrbach, A., E. Angevin, P. Poncet, M. Rouleau, G. Chavanel, A. Chapel, D. Thierry, A. Goiter, R. Hirsch, B. Charpentier, A. Senik, and F. Hirsch. 1999. The antibody-mediated endocytosis of G250 tumor-associated antigen allows targeted gene transfer to human renal-cell carcinoma in vitro. Cancer Gene Ther 6:564.
Erbacher, P., T. Bettinger, P. Belguise-Valladier, S. Zou. J. L. Coll. J. P. Behr, and J. S. Remy. 1999. Transfection and physical properties of various saccharide. poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI). J Gene Med 1:210.
Goud, B., P. Legrain, and G. Buttin. 1988. Antibody-mediated binding of a murine ecotropic moloney retroviral vector to human cells allows internalization but not the establishment of the pro viral state. Virology 163:251.
Heim, D. A., and C. E. Dunbar. 2000. Hematopoietic stem cell gene therapy: towards clinically significant gene transfer efficiency. Immunol Rev 178:29.
Henkart, P. A. 1996. ICE family proteases: mediators of all apoptotic cell death? Immunity 4:195.
Hirsch, F., P. Poncet, S. Freeman, R. E. Gress, D. H. Sachs, P. Druet, and R. Hirsch. 1993. Antifection: a new method for targeted gene transfection. Transpl Proc 25:138.
Kohler, G., and C. Milstein. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495.
Knudson, C. M., and S. J. Korsmeyer. 1997. Bcl-2 and Bαχ function independently to regulate cell death. Nature Genetics 16:358.
Mastrobattista, E., R. H. Kapel, M. H. Eggenhuisen, P. J. Roholl, D. J. Crommelin, W. E. Hennink, and G. Storm. 2001. Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells. Cancer Gene Ther 8:405.
Maurice, M., E. Verhoeyen, P. Salmon, D. Trono, S. J. Russell, and F. L. Cosset. 2002. Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell-activating polypeptide. Blood 99:2342.
Mulders, P., R. Figlin, J. B. deKernion, R. Wiltrout, M. Linehan, D. Parkinson, W. deWolf, and A. Belldegrun. 1997. Renal cell carcinoma: recent progress and future directions. Cancer Res 57:5189.
O’Neill, M. M., C. A. Kennedy, R. W. Barton, and R. J. Tatake. 2001. Receptor-mediated gene delivery to human peripheral blood mononuclear cells using anti-CD3 antibody coupled to polyethylenimine. Gene Ther 8:362.
Oosterwijk, E., D. J. Ruitter, P. J. Hoedemaeker, E. K. J. Pauwels, U. Jonas, J. Zwartendijck, and S. O. Wamaar. 1986. Monoclonal antibody G250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney. Int J Cancer 38:489.
Oosterwijk, E., F. M. J. Debruyne, and J. A. Schalken. 1995. The use of monoclonal antibody G250 in the therapy of renal-cell carcinoma. Semin Oncol 22:34.
Pelegrin, M., M. Marin, D. Noel, and M. Piechaczyk. 1998. Genetically engineered antibodies in gene transfer and gene therapy. Hum Gene Ther 9:2165.
Perales, J. C., T. Ferkol, H. Beegen, O. D. Ratnoff, and R. W. Hanson. 1994. Gene transfer in vivo: Sustained expression and regulation of genes introduced into the liver by receptortargeted uptake. Proc Natl Acad Sci USA 91:4086.
Poncet, P., A. Panczak, C. Goupy, K. Gustafsson, C. Blanpied, G. Chavanel, R. Hirsch, and F. Hirsch. 1996. Antifection: an antibody-mediated method to introduce genes into lymphoid cells in vitro and in vivo. Gene Ther 3:731.
Roselli, M., F. Guadagni, O. Buonomo, A. Belardi, P. Ferroni, A. Diodati, D. Anselmi, C. Cipriani, C. U. Casciani, J. Greiner, and J. Schlom. 1996. Tumor markers as targets for selective diagnostic and therapeutic procedures. Anticancer Res 16:2187.
Sato, N., C. Caux, T. Kitamura, Y. Watanabe, K. Arai, J. Banchereau, and A. Miyajima. 1993. Expression and factor-dependent modulation of the interleukin-3 receptor subunits on human hematopoietic cells. Blood 82:752.
Schwarzenberger, P., S. E. Spence, J. M. Gooya, D. Michiel, D. T. Curiel, F. W. Ruscetti, and J. R. Keller. 1996. Targeted gene transfer to human hematopoietic progenitor cell lines through the c-kit receptor. Blood 67:472.
Shi, N., and W. M. Pardridge. 2000. Noninvasive gene targeting to the brain. Proc Natl Acad Sci USA 97:7567.
Tai, Y. T., T. Strobel, D. Kufe, and S. A. Cannistra. 1999. In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the BAX gene. Cancer Res 59:2121.
Templeton, N. S., D. D. Lasic, P. M. Frederik, H. H. Strey, D. D. Roberts, and G. N. Pavlakis. 1997. Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol 15:647.
Tsuruta, Y., M. Mandai, I. Konishi, H. Kuroda, T. Kusakari, Y. Yura, A. A. Hamid, I. Tamura, M. Kariya, and S. Fujii. 2001. Combination effect of adenovirus-mediated pro-apoptotic bax gene transfer with cisplatin or paclitaxel treatment in ovarian cancer cell lines. Eur J Cancer 37:531.
Wagemaker, G., K. J. Neelis, and A. W. Wognum. 1995. Surface markers and growth factor receptors of immature hemopoietic stem cell subsets. Stem Cells 13Suppl 1:165.
Wagner, E., M. Zenke, M. Cotten, H. Beug, and M. L. Birnstiel. 1990. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc Natl Acad Sci USA 87:3410.
Wang, R. F., and S. A. Rosenberg. 1999. Human tumor antigens for cancer vaccine development. Immunol Rev 170:85.
Weichselbaum, R. R., and D. Kufe. 1997. Gene therapy of cancer. Lancet 349:10.
Wickham, T. J. 2000. Targeting adenovirus. Gene Ther 7:110.
Xu, L., C. C. Huang, W. Huang, W. H. Tang, A. Rait, Y. Z. Yin, I. Cruz, L. M. Xiang, K. F. Pirollo, and E. H. Chang. 2002. Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes. Mol Cancer Ther 1:337.
Zenke, M., P. Steinlein, E. Wagner, M. Cotten, H. Beug, and M. L. Birnstiel. 1990. Receptor-mediated endocytosis of transferrin-polycation conjugates: an efficient way to introduce DNA into hematopoietic cells. Proc Natl Acad Sci USA 87:3655.
Zhang, Y., H. Jeong Lee, R. J. Boado, and W. M. Pardridge. 2002. Receptor-mediated delivery of an antisense gene to human brain cancer cells. J Gene Med 4:183.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hirsch, F., Deas, O., Carvalho, G., Dürrbach, A., Thierry, D., Chapel, A. (2004). Antibodies, a Potent Tool to Target Genes into Designated Cells and Tissues. In: Subramanian, G. (eds) Antibodies. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-8877-5_7
Download citation
DOI: https://doi.org/10.1007/978-1-4419-8877-5_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4702-6
Online ISBN: 978-1-4419-8877-5
eBook Packages: Springer Book Archive